PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE

Aim. To analyze gender differences in pharmacotherapy and outcomes of ST-elevation myocardial infarction (STEMI) in patients of cardiology hospital in real clinical practice. Material and methods. A continuous pharmacoepidemiological analysis was performed on the base of 153 records of patients with...

Full description

Bibliographic Details
Main Authors: P. V. Dolotovskaya, E. Y. Rudnichenko, N. V. Furman, O. V. Reshet'ko
Format: Article
Language:English
Published: Столичная издательская компания 2015-09-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:http://www.rpcardio.ru/jour/article/view/274
_version_ 1797707959608803328
author P. V. Dolotovskaya
E. Y. Rudnichenko
N. V. Furman
O. V. Reshet'ko
author_facet P. V. Dolotovskaya
E. Y. Rudnichenko
N. V. Furman
O. V. Reshet'ko
author_sort P. V. Dolotovskaya
collection DOAJ
description Aim. To analyze gender differences in pharmacotherapy and outcomes of ST-elevation myocardial infarction (STEMI) in patients of cardiology hospital in real clinical practice. Material and methods. A continuous pharmacoepidemiological analysis was performed on the base of 153 records of patients with STEMI (men 102, women 51), consecutively admitted to the emergency department of cardiology hospital in the period from October 2010 to April 2011.<br />Results. Women were on average 10.6 years older than men, had significantly higher incidence of severe comorbid conditions and significantly fewer prescribed medications improving STEMI prognosis - thrombolytics (21% vs 50%; p&lt;0.05), statins (20% vs 53%; p&lt;0.05), beta-blockers (84% vs 91%; p&lt;0.05) and dual antiplatelet therapy (21% vs 59%; p&lt;0.05). Hospital mortality was significantly higher in women than this in men, at that mortality differences persisted for 12 months after discharge.<br />Conclusion. Older age, higher comorbidity rate, and lower treatment compliance with the current clinical recommendations in female STEMI patients in comparison with these in male STEMI patients contribute to higher hospital mortality and 12-month mortality after discharge in women with STEMI.
first_indexed 2024-03-12T06:15:13Z
format Article
id doaj.art-f272d4f2b31e4a4ebd5765701926a7da
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2024-03-12T06:15:13Z
publishDate 2015-09-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-f272d4f2b31e4a4ebd5765701926a7da2023-09-03T02:44:43ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-09-019665065410.1234/1819-6446-2013-6-650-654274PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICEP. V. Dolotovskaya0E. Y. Rudnichenko1N. V. Furman2O. V. Reshet'ko3Саратовский научно-исследовательский институт кардиологии, СаратовСаратовский государственный медицинский университет имени. В.И. Разумовског, СаратовСаратовский научно-исследовательский институт кардиологии, СаратовСаратовский государственный медицинский университет имени. В.И. Разумовског, СаратовAim. To analyze gender differences in pharmacotherapy and outcomes of ST-elevation myocardial infarction (STEMI) in patients of cardiology hospital in real clinical practice. Material and methods. A continuous pharmacoepidemiological analysis was performed on the base of 153 records of patients with STEMI (men 102, women 51), consecutively admitted to the emergency department of cardiology hospital in the period from October 2010 to April 2011.<br />Results. Women were on average 10.6 years older than men, had significantly higher incidence of severe comorbid conditions and significantly fewer prescribed medications improving STEMI prognosis - thrombolytics (21% vs 50%; p&lt;0.05), statins (20% vs 53%; p&lt;0.05), beta-blockers (84% vs 91%; p&lt;0.05) and dual antiplatelet therapy (21% vs 59%; p&lt;0.05). Hospital mortality was significantly higher in women than this in men, at that mortality differences persisted for 12 months after discharge.<br />Conclusion. Older age, higher comorbidity rate, and lower treatment compliance with the current clinical recommendations in female STEMI patients in comparison with these in male STEMI patients contribute to higher hospital mortality and 12-month mortality after discharge in women with STEMI.http://www.rpcardio.ru/jour/article/view/274инфаркт миокардафармакотерапияисходгендерные различия
spellingShingle P. V. Dolotovskaya
E. Y. Rudnichenko
N. V. Furman
O. V. Reshet'ko
PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE
Рациональная фармакотерапия в кардиологии
инфаркт миокарда
фармакотерапия
исход
гендерные различия
title PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE
title_full PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE
title_fullStr PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE
title_full_unstemmed PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE
title_short PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE
title_sort pharmacotherapy and outcomes of acute st elevation myocardial infarction gender differences in real clinical practice
topic инфаркт миокарда
фармакотерапия
исход
гендерные различия
url http://www.rpcardio.ru/jour/article/view/274
work_keys_str_mv AT pvdolotovskaya pharmacotherapyandoutcomesofacutestelevationmyocardialinfarctiongenderdifferencesinrealclinicalpractice
AT eyrudnichenko pharmacotherapyandoutcomesofacutestelevationmyocardialinfarctiongenderdifferencesinrealclinicalpractice
AT nvfurman pharmacotherapyandoutcomesofacutestelevationmyocardialinfarctiongenderdifferencesinrealclinicalpractice
AT ovreshetko pharmacotherapyandoutcomesofacutestelevationmyocardialinfarctiongenderdifferencesinrealclinicalpractice